Can concomitant-boost accelerated radiotherapy be adopted as routine treatment for head-and-neck cancers? A 10-year single-institution experience
Contributeurs/tricesAllal, Abdelkarim Said; Taussky, Daniel; Mach, Nicolas; Becker, Minerva; Bieri, Sabine; Dulguerov, Pavel
Publié dansInternational journal of radiation oncology, biology, physics, vol. 58, no. 5, p. 1431-1436
Date de publication2004
Résumé
Mots-clés
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols/therapeutic use
- Carcinoma, Squamous Cell/drug therapy/radiotherapy/surgery
- Cause of Death
- Cisplatin/administration & dosage
- Combined Modality Therapy
- Dose Fractionation
- Feasibility Studies
- Female
- Fluorouracil/administration & dosage
- Head and Neck Neoplasms/drug therapy/radiotherapy/surgery
- Humans
- Male
- Middle Aged
- Statistics as Topic
Groupe de recherche
Citation (format ISO)
ALLAL, Abdelkarim Said et al. Can concomitant-boost accelerated radiotherapy be adopted as routine treatment for head-and-neck cancers? A 10-year single-institution experience. In: International journal of radiation oncology, biology, physics, 2004, vol. 58, n° 5, p. 1431–1436. doi: 10.1016/j.ijrobp.2003.09.017
Fichiers principaux (1)
Article (Published version)
Identifiants
- PID : unige:33112
- DOI : 10.1016/j.ijrobp.2003.09.017
- PMID : 15050320
ISSN du journal0360-3016